125 related articles for article (PubMed ID: 9291437)
1. E-cadherin expression in upper-urinary-tract carcinoma.
Nakanishi K; Kawai T; Torikata C; Aurues T; Ikeda T
Int J Cancer; 1997 Aug; 74(4):446-9. PubMed ID: 9291437
[TBL] [Abstract][Full Text] [Related]
2. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
[TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Kawai T; Torikata C; Aurues T; Ikeda T
Virchows Arch; 1998 May; 432(5):445-50. PubMed ID: 9645444
[TBL] [Abstract][Full Text] [Related]
6. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
7. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
[TBL] [Abstract][Full Text] [Related]
8. Growth factors and oncogene products in transitional cell carcinoma.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
10. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
Milojevic B; Djokic M; Sipetic-Grujicic S; Milenkovic-Petronic D; Vuksanovic A; Bumbasirevic U; Vukovic I; Dragicevic D; Tulic C
BJU Int; 2012 Apr; 109(7):1037-42. PubMed ID: 21883837
[TBL] [Abstract][Full Text] [Related]
11. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
[TBL] [Abstract][Full Text] [Related]
12. [Urothelial cancer of the upper urinary tract].
Jurincic-Winkler C; Horlbeck R; Gasser A; Glenewinkel J; Klippel KF
Urologe A; 1993 Jul; 32(4):295-9. PubMed ID: 8372411
[TBL] [Abstract][Full Text] [Related]
13. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival.
Milojevic B; Djokic M; Sipetic-Grujicic S; Milenkovic-Petronic D; Vuksanovic A; Dragicevic D; Bumbasirevic U; Tulic C
Int Urol Nephrol; 2011 Sep; 43(3):729-35. PubMed ID: 21350863
[TBL] [Abstract][Full Text] [Related]
15. WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.
Otto W; Breyer J; Herdegen S; Eder F; Bertz S; May M; Mayr R; Lausenmeyer EM; Denzinger S; van Rhijn BW; Burger M; Hartmann A
Int Urol Nephrol; 2017 Mar; 49(3):431-437. PubMed ID: 28035618
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell carcinoma of upper urinary tract: some prognostic indicators.
Gawley WF; Harney J; Glacken P; Hehir M; Rogers A; McKelvie G
Urology; 1989 Jun; 33(6):459-61. PubMed ID: 2728147
[TBL] [Abstract][Full Text] [Related]
17. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Torikata C
Hum Pathol; 1996 Dec; 27(12):1336-40. PubMed ID: 8958308
[TBL] [Abstract][Full Text] [Related]
19. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V
Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165
[TBL] [Abstract][Full Text] [Related]
20. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
